Detecting Aortic Atherosclerosis by Non-obstructive Angioscopy in Patients with COronary Heart Disease
Not Applicable
Recruiting
- Conditions
- Coronary heart disease
- Registration Number
- JPRN-UMIN000029745
- Lead Sponsor
- Cardiovascular Center, Osaka Gyoumeikan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
Not provided
Exclusion Criteria
use of intra-aortic balloon pumping or percutaneous cardiopulmonary support, hemodynamic instability (i.e., Killip state >2 or cardiogenic shock), known aortic dissection, aortic aneurysm larger than the size indicated for surgery, (thoracic diameter >=6 mm or abdominal diameter >=5 mm), allergy to contrast media, and pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aortic atherosclerosis progression in coronary heart disease patients using non-obstructive angioscopy?
How does non-obstructive angioscopy compare to CT angiography in detecting aortic atherosclerosis in CHD patients?
Which biomarkers correlate with aortic plaque burden in coronary heart disease patients during angioscopy-based assessments?
What are the safety profiles and management strategies for complications during non-obstructive aortic angioscopy procedures?
Are there novel imaging agents or technologies synergizing with non-obstructive angioscopy for aortic atherosclerosis detection in CHD?